Predictive Value of Serum microRNA-29b-3p in Recurrence of Atrial Fibrillation After Radiofrequency Catheter Ablation

References

• Cao F, Li Z, Ding W-M, Yan L, Zhao Q-Y. LncRNA PVT1 regulates atrial fibrosis via miR-128-3p-SP1-TGF-β1-Smad axis in atrial fibrillation. Mol Med. 2019;25(1):7. doi:10.1186/s10020-019-0074-5
   PubMedGoogle Scholar
• Steinberg BA, Holmes DN, Pieper K, et al. Factors associated with large improvements in health-related quality of life in patients with atrial fibrillation: results from ORBIT-AF. Circ Arrhythm Electrophysiol. 2020;13(5):e007775. doi:10.1161/CIRCEP.119.007775
   PubMed Web of Science ®Google Scholar
• Magnani JW, Wang N, Benjamin EJ, et al. Atrial fibrillation and declining physical performance in older adults: the health, aging, and body composition study. Circ Arrhythm Electrophysiol. 2016;9(5):e003525. doi:10.1161/CIRCEP.115.003525
   PubMed Web of Science ®Google Scholar
• Guan Z, Zhang YJ, Liu L, et al. The association of preoperative atrial fibrillation with post-cardiopulmonary bypass hyperfibrinolysis in rheumatic valvular heart disease patients. Heart Lung. 2019;48(6):515–518. doi:10.1016/j.hrtlng.2019.05.014
   PubMedGoogle Scholar
• Li CY, Zhang JR, Hu WN, Li SN. Atrial fibrosis underlying atrial fibrillation (Review). Int J Mol Med. 2021;47:3. doi:10.3892/ijmm.2020.4842
   Web of Science ®Google Scholar
• Begg GA, Swoboda PP, Karim R, et al. Imaging, biomarker and invasive assessment of diffuse left ventricular myocardial fibrosis in atrial fibrillation. J Cardiovasc Magn Reson. 2020;22(1):13. doi:10.1186/s12968-020-0603-y
   PubMed Web of Science ®Google Scholar
• Yi F, Hou W, Zhou C, et al. Radiofrequency ablation versus antiarrhythmic drug therapy for atrial fibrillation: meta-analysis of safety and efficacy. J Cardiovasc Pharmacol. 2019;73(4):241–247. doi:10.1097/FJC.0000000000000654
   PubMed Web of Science ®Google Scholar
• Shi J, Chen L, Chen S, Wu B, Yang K, Hu X. Circulating long noncoding RNA, GAS5, as a novel biomarker for patients with atrial fibrillation. J Clin Lab Anal. 2021;35(1):e23572. doi:10.1002/jcla.23572
   PubMed Web of Science ®Google Scholar
• Wang J, Song S, Xie C, et al. MicroRNA profiling in the left atrium in patients with non-valvular paroxysmal atrial fibrillation. BMC Cardiovasc Disord. 2015;15:97. doi:10.1186/s12872-015-0085-2
   PubMed Web of Science ®Google Scholar
• Zhelankin AV, Vasiliev SV, Stonogina DA, et al. Elevated plasma levels of circulating extracellular miR-320a-3p in patients with paroxysmal atrial fibrillation. Int J Mol Sci. 2020;21:10. doi:10.3390/ijms21103485
   Web of Science ®Google Scholar
• Torrado M, Franco D, Lozano-Velasco E, et al. A MicroRNA-transcription factor blueprint for early atrial arrhythmogenic remodeling. Biomed Res Int. 2015;2015:263151. doi:10.1155/2015/263151
   PubMed Web of Science ®Google Scholar
• van den Berg NWE, Kawasaki M, Berger WR, et al. MicroRNAs in atrial fibrillation: from expression signatures to functional implications. Cardiovasc Drugs Ther. 2017;31(3):345–365. doi:10.1007/s10557-017-6736-z
   PubMed Web of Science ®Google Scholar
• da Silva AM, de Araujo JN, de Freitas RC, Silbiger VN. Circulating MicroRNAs as potential biomarkers of atrial fibrillation. Biomed Res Int. 2017;2017:7804763. doi:10.1155/2017/7804763
   PubMed Web of Science ®Google Scholar
• Yang Q, Wu F, Mi Y, et al. Aberrant expression of miR-29b-3p influences heart development and cardiomyocyte proliferation by targeting NOTCH2. Cell Prolif. 2020;53(3):e12764. doi:10.1111/cpr.12764
   PubMed Web of Science ®Google Scholar
• Yang J, Chen Y, Jiang K, et al. MicroRNA-182 supplies negative feedback regulation to ameliorate lipopolysaccharide-induced ALI in mice by targeting TLR4. J Cell Physiol. 2020;235(9):5925–5937. doi:10.1002/jcp.29504
   PubMed Web of Science ®Google Scholar
• Xue Y, Fan X, Yang R, Jiao Y, Li Y. miR-29b-3p inhibits post-infarct cardiac fibrosis by targeting FOS. Biosci Rep. 2020;40:9. doi:10.1042/BSR20201227
   Web of Science ®Google Scholar
• Han X, Wang S, Yong Z, Zhang X, Wang X. miR-29b ameliorates atrial fibrosis in rats with atrial fibrillation by targeting TGFbetaRIota and inhibiting the activation of Smad-2/3 pathway. J Bioenerg Biomembr. 2022;54(2):81–91. doi:10.1007/s10863-022-09934-7
   PubMed Web of Science ®Google Scholar
• Guo Y, Sun Z, Chen M, Lun J. LncRNA TUG1 regulates proliferation of cardiac fibroblast via the miR-29b-3p/TGF-beta1 Axis. Front Cardiovasc Med. 2021;8:646806. doi:10.3389/fcvm.2021.646806
   PubMed Web of Science ®Google Scholar
• Lv X, Lu P, Hu Y, Xu T. Overexpression of MiR-29b-3p inhibits atrial remodeling in rats by targeting PDGF-B signaling pathway. Oxid Med Cell Longev. 2021;2021:3763529. doi:10.1155/2021/3763529
   PubMed Web of Science ®Google Scholar
• Guo F, Tang C, Huang B, et al. LncRNA H19 drives proliferation of cardiac fibroblasts and collagen production via suppression of the miR-29a-3p/miR-29b-3p-VEGFA/TGF-beta axis. Mol Cells. 2022;45(3):122–133. doi:10.14348/molcells.2021.0066
   PubMed Web of Science ®Google Scholar
• Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur J Cardiothorac Surg. 2016;50(5):e1–e88. doi:10.1093/ejcts/ezw313
   PubMed Web of Science ®Google Scholar
• Wang G, Cheng B, Jia R, Tan B, Liu W. Altered expression of microRNA-92b-3p predicts survival outcomes of patients with prostate cancer and functions as an oncogene in tumor progression. Oncol Lett. 2021;21(1):4. doi:10.3892/ol.2020.12265
   PubMed Web of Science ®Google Scholar
• Han X, Chen C, Cheng G, et al. Serum fibroblast growth factor 21 levels are increased in atrial fibrillation patients. Cytokine. 2015;73(1):176–180. doi:10.1016/j.cyto.2015.02.019
   PubMed Web of Science ®Google Scholar
• Liu L, Su J, Li R, Luo F. Changes in intestinal flora structure and metabolites are associated with myocardial fibrosis in patients with persistent atrial fibrillation. Front Nutr. 2021;8:702085. doi:10.3389/fnut.2021.702085
   PubMed Web of Science ®Google Scholar
• Popa MA, Kottmaier M, Risse E, et al. Early arrhythmia recurrence after catheter ablation for persistent atrial fibrillation: is it predictive for late recurrence? Clin Res Cardiol. 2022;111(1):85–95. doi:10.1007/s00392-021-01934-8
   PubMed Web of Science ®Google Scholar
• Chen J, Liu M, Luo X, et al. Exosomal miRNA-486-5p derived from rheumatoid arthritis fibroblast-like synoviocytes induces osteoblast differentiation through the Tob1/BMP/Smad pathway. Biomater Sci. 2020;8(12):3430–3442. doi:10.1039/c9bm01761e
   PubMed Web of Science ®Google Scholar
• Wang R, Yi X, Li X, Jiang X. Fibroblast growth factor-21 is positively associated with atrial fibrosis in atrial fibrillation patients with rheumatic heart disease. Int J Clin Exp Pathol. 2015;8(11):14901–14908.
   PubMed Web of Science ®Google Scholar
• Schotten U, Verheule S, Kirchhof P, Goette A. Pathophysiological mechanisms of atrial fibrillation: a translational appraisal. Physiol Rev. 2011;91(1):265–325. doi:10.1152/physrev.00031.2009
   PubMed Web of Science ®Google Scholar
• Clauss S, Wakili R, Hildebrand B, et al. MicroRNAs as biomarkers for acute atrial remodeling in marathon runners (the miRathon study--A sub-study of the Munich marathon study). PLoS One. 2016;11(2):e0148599. doi:10.1371/journal.pone.0148599
   PubMed Web of Science ®Google Scholar
• Dawson K, Wakili R, Ordog B, et al. MicroRNA29: a mechanistic contributor and potential biomarker in atrial fibrillation. Circulation. 2013;127(14):1466–1475. doi:10.1161/CIRCULATIONAHA.112.001207
   PubMed Web of Science ®Google Scholar
• Dorn L, Kranzburg A, Saumell A, Gregory T, Reich S. Radiofrequency catheter ablation for atrial fibrillation. JAAPA. 2015;28(5):40–45. doi:10.1097/01.JAA.0000464275.36493.2d
   PubMedGoogle Scholar
• Zhou Q, Maleck C, von Ungern-Sternberg SNI, et al. Circulating MicroRNA-21 correlates with left atrial low-voltage areas and is associated with procedure outcome in patients undergoing atrial fibrillation ablation. Circ Arrhythm Electrophysiol. 2018;11(6):e006242. doi:10.1161/CIRCEP.118.006242
   PubMed Web of Science ®Google Scholar
• Li J, Cen B, Chen S, He Y. MicroRNA-29b inhibits TGF-beta1-induced fibrosis via regulation of the TGF-beta1/Smad pathway in primary human endometrial stromal cells. Mol Med Rep. 2016;13(5):4229–4237. doi:10.3892/mmr.2016.5062
   PubMed Web of Science ®Google Scholar
• Coteli C, Hazirolan T, Aytemir K, et al. Evaluation of atrial fibrosis in atrial fibrillation patients with three different methods. Turk J Med Sci. 2021. doi:10.3906/sag-2103-194
   PubMed Web of Science ®Google Scholar
• Chua W, Purmah Y, Cardoso VR, et al. Data-driven discovery and validation of circulating blood-based biomarkers associated with prevalent atrial fibrillation. Eur Heart J. 2019;40(16):1268–1276. doi:10.1093/eurheartj/ehy815
   PubMed Web of Science ®Google Scholar
• Jiang N, Liu HX, Liang HY, Feng XH, Liu BY, Zhou YY. Osteogenic differentiation characteristics of Hip joint capsule fibroblasts obtained from patients with ankylosing spondylitis. Ann Transl Med. 2021;9(4):331. doi:10.21037/atm-20-7817
   PubMed Web of Science ®Google Scholar
• Kiliszek M, Maciak K, Maciejak A, et al. Serum microRNA in patients undergoing atrial fibrillation ablation. Sci Rep. 2020;10(1):4424. doi:10.1038/s41598-020-61322-6
   PubMed Web of Science ®Google Scholar
• Santulli G, Iaccarino G, De Luca N, Trimarco B, Condorelli G. Atrial fibrillation and microRNAs. Front Physiol. 2014;5:15. doi:10.3389/fphys.2014.00015
   PubMed Web of Science ®Google Scholar
• Weber JA, Baxter DH, Zhang S, et al. The microRNA spectrum in 12 body fluids. Clin Chem. 2010;56(11):1733–1741. doi:10.1373/clinchem.2010.147405
   PubMed Web of Science ®Google Scholar
• Cao Y, Cui L. Identifying the key microRNAs implicated in atrial fibrillation. Anatol J Cardiol. 2021;25(6):429–436. doi:10.14744/AnatolJCardiol.2020.41625
   PubMed Web of Science ®Google Scholar